EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults

NCT01026246 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

DRUG: Placebo
BIOLOGICAL: EBA-175 RII-NG Malaria Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)